STUDY PERIOD | |||||||
---|---|---|---|---|---|---|---|
Enrollment | allocation | Post-allocation | Close-out | ||||
Time point** | 0 | day 1 | in-hospital | at discharge | day 30 | 1 year | |
Enrollment: | |||||||
Eligibility screen | X | ||||||
Informed consent | X | ||||||
History and ECG | X | ||||||
Allocation | X | ||||||
Interventions: | |||||||
Medical treatment* | X | ||||||
Invasive treatment strategy | X | ||||||
Assessments: | |||||||
Echocardiography and frailty score | X | ||||||
QoL and angina questionnaire | X | X | |||||
Adverse events | X | X | X | X | |||
If symptoms, additional assessments** | X | X | X | ||||
Outcome: | |||||||
MACCE*** | X | X§ | |||||
Myocardial infarction | X | ||||||
All-cause mortality | X | ||||||
Safety measure: bleeding | X | X | X | X |